文献速递高血压心力衰竭与心肌病心律失常

阻塞性睡眠呼吸暂停与心血管疾病:美国心脏协会科学声明

Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
PubMed 文献 · Circulation · 2021-06-21

该科学声明指出,中年男性约34%、女性约17%符合OSA诊断标准,在高血压、心衰、冠心病、房颤等心血管病患者中患病率高达40%–80%,但临床常被低估和治疗不足。声明推荐对难治性高血压、肺高血压及复律或消融后复发房颤患者筛查OSA,并建议所有OSA患者考虑行为干预和减重,重度OSA应提供CPAP。

要点

  • 难治性/控制不佳高血压、肺高血压、复律或消融后复发房颤患者应筛查OSA。
  • NYHA II–IV级心衰伴睡眠呼吸障碍疑似或日间过度嗜睡,应行正式睡眠评估。
  • 所有OSA患者应考虑治疗,重度OSA提供CPAP,轻中度可考虑口腔矫治器。

核心结论

  • OSA在心血管病患者中患病率高但常被低估和治疗不足,声明给出了特定心血管病人群的筛查与治疗推荐。

研究设计与样本

  • 美国心脏协会(AHA)科学声明,基于文献综述与专家共识形成推荐。

主要发现

  • 约34%中年男性和17%中年女性符合OSA诊断标准。
  • 高血压、心衰、冠心病、肺高血压、房颤和卒中患者中OSA患病率高达40%–80%。
  • 夜间发生心绞痛、心肌梗死、心律失常或植入式心律转复除颤器(ICD)适当放电的患者可能尤其合并睡眠呼吸暂停。

关键数值与推荐

  • 推荐对难治性/控制不佳高血压、肺高血压、复律或消融后复发房颤患者筛查OSA。
  • NYHA II–IV级心衰伴睡眠呼吸障碍疑似或日间过度嗜睡,正式睡眠评估是合理的。
  • 心动过缓-心动过速综合征或室性心动过速患者、心脏性猝死幸存者,全面睡眠评估后怀疑睡眠呼吸暂停时应考虑评估。
  • 卒中后筛查与治疗存在临床均势。
  • 所有OSA患者应考虑治疗包括行为干预和减重;重度OSA应提供CPAP,轻中度或CPAP不耐受者可考虑口腔矫治器;应随访睡眠检测评估疗效。

临床怎么用

  • 在心内科实践中对上述特定心血管病人群主动筛查OSA,确诊后给予行为干预、减重及CPAP或口腔矫治器治疗,并随访睡眠检测评估疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Obstructive sleep apnea (OSA) is characterized by recurrent complete and partial upper airway obstructive events, resulting in intermittent hypoxemia, autonomic fluctuation, and sleep fragmentation. Approximately 34% and 17% of middle-aged men and women, respectively, meet the diagnostic criteria for OSA. Sleep disturbances are common and underdiagnosed among middle-aged and older adults, and the prevalence varies by race/ethnicity, sex, and obesity status. OSA prevalence is as high as 40% to 80% in patients with hypertension, heart failure, coronary artery disease, pulmonary hypertension, atrial fibrillation, and stroke. Despite its high prevalence in patients with heart disease and the vulnerability of cardiac patients to OSA-related stressors and adverse cardiovascular outcomes, OSA is often underrecognized and undertreated in cardiovascular practice. We recommend screening for OSA in patients with resistant/poorly controlled hypertension, pulmonary hypertension, and recurrent atrial fibrillation after either cardioversion or ablation. In patients with New York Heart Association class II to IV heart failure and suspicion of sleep-disordered breathing or excessive daytime sleepiness, a formal sleep assessment is reasonable. In patients with tachy-brady syndrome or ventricular tachycardia or survivors of sudden cardiac death in whom sleep apnea is suspected after a comprehensive sleep assessment, evaluation for sleep apnea should be considered. After stroke, clinical equipoise exists with respect to screening and treatment. Patients with nocturnally occurring angina, myocardial infarction, arrhythmias, or appropriate shocks from implanted cardioverter-defibrillators may be especially likely to have comorbid sleep apnea. All patients with OSA should be considered for treatment, including behavioral modifications and weight loss as indicated. Continuous positive airway pressure should be offered to patients with severe OSA, whereas oral appliances can be considered for those with mild to moderate OSA or for continuous positive airway pressure-intolerant patients. Follow-up sleep testing should be performed to assess the effectiveness of treatment.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021. PMID: 34148375. doi:10.1161/CIR.0000000000000988

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。